In our study, however, the proportions of CD226+ cells in all B cell subsets were higher in SLE patients than in HCs, indicating that CD226 upregulation may not reflect alterations in the proportions of B cell subsets in SLE. The gene discussed is CD226; the disease is systemic lupus erythematosus.